Related Experiment Video
Updated: Jul 18, 2026
07:35
A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
Published on: October 13, 2023
The PharmGKB: integration, aggregation, and annotation of pharmacogenomic data and knowledge
A E Hodge1, R B Altman, T E Klein
1Department of Genetics, Stanford University, Stanford, California, USA.
Clinical Pharmacology and Therapeutics
|December 23, 2006
Summary
PharmGKB curates pharmacogenetic and pharmacogenomic data to link genes, drugs, and diseases. This knowledge base supports research into how gene variations affect drug responses and disease outcomes.
Area of Science:
- Pharmacogenetics and Pharmacogenomics
- Genetics and Drug Metabolism
Background:
- The Pharmacogenetics and Pharmacogenomics Knowledge Base (PharmGKB) is a comprehensive resource.
- It focuses on curating information linking genetic variations to drug responses and disease.
- Data is sourced from scientific literature and direct research data deposition.
Discussion:
- PharmGKB establishes relationships between genes, drugs, and diseases.
- It highlights the impact of genetic variations on these complex interactions.
- The knowledge base aims to facilitate a deeper understanding of personalized medicine.
Key Insights:
- Genotype-phenotype relationships are central to PharmGKB's curation.
- Information is gathered to elucidate how genetic makeup influences treatment efficacy and safety.
- This resource serves as a critical tool for researchers in the field.
Outlook:
- PharmGKB seeks to catalyze further pharmacogenetic and pharmacogenomic research.
- The goal is to advance the application of genetic information in clinical practice.
- Future efforts will continue to expand the knowledge base for improved drug development and patient care.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
03:36Genome Annotation and Assembly
The genome refers to all of the genetic material in an organism. It can range from a few million base pairs in microbial cells to several billion base pairs in many eukaryotic organisms. Genome assembly refers to the process of taking the DNA sequencing data and putting it all back together in a correct order to create a close representation of the original genome. This is followed by the identification of functional elements on the newly assembled genome, a process called genome annotation.
01:16Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...